Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 49.87M P/E - EPS this Y 14.10% Ern Qtrly Grth -
Income -76.08M Forward P/E -0.66 EPS next Y 41.10% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -57.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -77.00%
Recommedations 2.20 Quick Ratio 1.15 Shares Outstanding 73.55M 52W Low Chg 319.00%
Insider Own 10.63% ROA -91.92% Shares Float 28.37M Beta 0.94
Inst Own 60.65% ROE -543.23% Shares Shorted/Prior 148.44K/181.06K Price 0.68
Gross Margin - Profit Margin - Avg. Volume 1,269,460 Target Price 5.88
Oper. Margin - Earnings Date Mar 20 Volume 224,834 Change -2.16%
About Axcella Health Inc.

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Axcella Health Inc. News
01/25/23 Biotech Stock Roundup: BLUE Down on Share Issuance, CPRX Falls on Generic Filing & More
01/25/23 With lean staff, low cash, Axcella races ahead with Long Covid drug
01/24/23 Benzinga's Talk of the Town: Top Social Trending Stories You Need To Know
01/24/23 Why Are Axcella Health Shares Gaining Today?
01/23/23 Axcella Announces Regulatory Path to Registration of AXA1125 for Long COVID Fatigue
12/15/22 Axcella Therapeutics Puts Development Of NASH Program Aside, Reduces Workforce By 85%
12/14/22 Axcella Announces Program Reprioritization and Corporate Restructuring
12/08/22 Great news for Axcella Health Inc. (NASDAQ:AXLA): Insiders acquired stock in large numbers last year
11/11/22 Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11/03/22 Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
11/01/22 Axcella Reports Third Quarter Financial Results and Provides Business Update
10/27/22 Axcella Therapeutics to Report Third Quarter 2022 Financial Results on November 1, 2022
10/14/22 Axcella Therapeutics to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
10/13/22 Axcella Therapeutics Announces $34.2 Million Registered Direct Offering of Common Stock Priced At The Market: Appoints Two New Board Members
09/29/22 Axcella Shares Jump Despite Mixed Bag Data From Mid-Stage NASH Trial
09/29/22 Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH)
09/17/22 Institutions profited after Axcella Health Inc.'s (NASDAQ:AXLA) market cap rose US$35m last week butprivate equity firms profited the most
09/12/22 Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
08/12/22 Edited Transcript of AXLA.OQ earnings conference call or presentation 12-Aug-22 12:30pm GMT
08/12/22 Axcella Reports Second Quarter Financial Results and Provides Business Update
AXLA Chatroom

User Image shortablestocks Posted - 1 hour ago

Zero shares available to short currently in $AXLA. https://shortablestocks.com/?AXLA

User Image shortablestocks Posted - 3 hours ago

$AXLA is short sale restricted for 2023-01-30. https://www.shortablestocks.com/?AXLA

User Image dividendinvestorbyeagle Posted - 3 hours ago

$AXLA close increased > 10% (Axcella Health Inc) https://www.dividendinvestor.com/dividend-news/?symbol=axla

User Image Mounting_Mayhem Posted - 1 day ago

$AXLA Clearly the automated equity analyst needs a new job.... πŸ€£πŸ˜‚

User Image intratio Posted - 1 day ago

https://www.intratio.com/stock-forecast/AXLA Axcella Health Inc The predictive model deduces that the price action of this stock will plummet in in the coming week and is anticipated to lose heights in the next 90 days $AXLA

User Image intratio Posted - 1 day ago

https://www.intratio.com/stock-forecast/AXLA The statistical model is predicting the stock price of this company plainly has a bad short-term setup and projects a dramatically gloomy future $AXLA

User Image ValueTraderA Posted - 2 days ago

Today's Top Pull Back Play watchlist. Watching these for a potential bounce back up next week. Team Arcadia Watchlist: 362k volume $PXMD -10% 969k volume $AXLA -10% 125k volume $PCSA -9.79% 2.2m volume $CRC -9.76% 404m volume $XELA -9.61% Team Arcadia is filled with experienced traders with triple digit track record gains. Trading is a team game, let's win together against the algos & top .1% Check out our ABSOLUTELY FREE stocks community filled with educational content, helpful pro traders and entry & exit ideas. (Link in my profile bio)

User Image BidaskBot Posted - 2 days ago

AxcellaHealth $AXLA BidaskScore is Upgraded to Sold https://bidaskclub.com/news/company/2023-01-26/AXLA

User Image cosmanot Posted - 2 days ago

$AXLA

User Image Sendingit07 Posted - 3 days ago

$FOXO congrats guys, $AXLA will do the same

User Image Sendingit07 Posted - 3 days ago

$AXLA burn this short. We just had great news

User Image intratio Posted - 3 days ago

The artificial intelligence deduces the price of this stock will immediately drop precipitously and has really poor long-term fundamentals $AXLA

User Image MissHollandia Posted - 3 days ago

$AXLA $TOUR $MEDS

User Image TradeAlertsTeam Posted - 3 days ago

🚨Relative Volume Increase🚨 Part 2 $FOXO $TOUR $MDNA $AXLA $ASXC Stay tune for more ideas! You know where to find our team!

User Image Alejos11 Posted - 3 days ago

Alert performance update1 $EZGO alert is πŸ†™ 121% $TOUR πŸ†™ 248% $EVOK πŸ†™ 144% $BZFD πŸ†™ 99% $AXLA πŸ†™ 250%

User Image ValueTraderA Posted - 3 days ago

Team Arcadia Watchlist - Today's Top Momentum Play with over 100k volume. Watching these for potentially more upside continuation this week. 916k volume $MDNA +22.23% 2.3m volume $AXLA +22.22% 5.3m volume $ASXC +21.6% 3m volume $KALA +20.98% 137k volume $EVOK +20.58% Team Arcadia are filled with experienced traders with triple digit track record gains. Trading is a team game, let's win together against the algos & top .1% Feel free to check out our ABSOLUTELY FREE community filled with educational content, helpful pro traders and entry and exit ideas. (Link in my profile bio)

User Image Sendingit07 Posted - 3 days ago

$AXLA I'm sure there trying to get it above $1 to meet requirements

User Image TheRealCharlesLeclerc Posted - 3 days ago

$TCBP Great chart. Nice dip to reset indicators. Im seeing continuation tomorrow with big squeeze in the morning above 7-8$. Very strong here. $MEDS Strong run here. Would be great to see it back at .60$ $KALA Nice 21% up today. 21$+ lets gooo $AXLA 22% and chart is looking perfect $TOUR 3$ breakout triggers the squeeze.

User Image MissHollandia Posted - 3 days ago

$CDLX πŸš€πŸš€πŸš€πŸš€πŸ™ $AXLA Axcella Gains on Regulatory Update: Shares of clinical-stage biotechnology company Axcella Therapeutics AXLA surged after the company announced a regulatory path to the registration of AXA1125 in the treatment of long COVID Fatigue. Axcella received regulatory guidance from the U.K.’s regulatory agency, The Medicines and Healthcare products Regulatory Agency (β€œMHRA”), supporting a single trial that could serve as the registration trial for patients with long COVID fatigue. The company and MHRA also aligned on key measurements, including primary endpoint and trial design. Axcella will meet the MHRA shortly to discuss the Innovative Licensing and Access Pathway (ILAP) application. In addition, Axcella submitted an investigational new drug (IND) application to the FDA for a phase IIb/III trial. $COMS $COSM $MULN

User Image MissHollandia Posted - 3 days ago

$NVVE πŸš€πŸš€πŸš€ $AXLA πŸš€πŸš€πŸš€Axcella Gains on Regulatory Update: Shares of clinical-stage biotechnology company Axcella Therapeutics AXLA surged after the company announced a regulatory path to the registration of AXA1125 in the treatment of long COVID Fatigue. Axcella received regulatory guidance from the U.K.’s regulatory agency, The Medicines and Healthcare products Regulatory Agency (β€œMHRA”), supporting a single trial that could serve as the registration trial for patients with long COVID fatigue. The company and MHRA also aligned on key measurements, including primary endpoint and trial design. Axcella will meet the MHRA shortly to discuss the Innovative Licensing and Access Pathway (ILAP) application. In addition, Axcella submitted an investigational new drug (IND) application to the FDA for a phase IIb/III trial.

User Image PennyBarron007 Posted - 3 days ago

$AXLA It needs volume. I'm almost ready to spam other tickers just to get some attention for this baby.

User Image Alejos11 Posted - 3 days ago

$AXLA 250%

User Image ChillC30 Posted - 3 days ago

$AXLA This pasts .8 levels next will be 1.3

User Image tickeron Posted - 3 days ago

How to make the right investment? Compare $AXLA vs. $MIRO. #AxcellaHealth https://srnk.us/go/4350567

User Image gtrades31 Posted - 3 days ago

...𝐓op 𝐏enny 𝐒tocks so far..πŸ‘ˆ πŸ‘€πŸ’ŽπŸ’ΉπŸ”₯πŸ”₯ $BZFD +175% 152𝐌 (79k) +49% P&L $FOXO +49% 13𝐌 (723k) +25% P&L $GFAI +27% 15𝐌 (5m) +16% P&L $AXLA +22% 1𝐌 (3m) +13% P&L

User Image KyleK4759 Posted - 3 days ago

$AXLA boom!

User Image KyleK4759 Posted - 3 days ago

$AXLA big wall at .73

User Image KyleK4759 Posted - 3 days ago

$AXLA keeps hitting heavy walls. Must be some big sell orders that’s stopping upward movement

User Image Sendingit07 Posted - 3 days ago

$AXLA let's roll

User Image tickeron Posted - 3 days ago

Perhaps this is a good chance to make a trade? $AXLA enters an Uptrend because Momentum Indicator exceeded the 0 level on January 6, 2023. View odds for this and other indicators: https://srnk.us/go/4350307

Analyst Ratings
SVB Leerink Market Perform Dec 16, 22
HC Wainwright & Co. Neutral Dec 15, 22
Chardan Capital Buy Nov 2, 22
HC Wainwright & Co. Buy Oct 3, 22
HC Wainwright & Co. Buy Aug 3, 22
SVB Leerink Outperform Aug 3, 22
Chardan Capital Buy May 9, 22
SVB Leerink Outperform Mar 31, 22
Chardan Capital Buy Nov 16, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hinshaw William President & CEO President & CEO Oct 17 Sell 1.56 16,000 24,960 82,012 10/19/22
Flagship Ventures Fund IV Gene... 10% Owner 10% Owner Oct 13 Buy 1.64 10,383,760 17,029,366 3,048,780 10/17/22
Koziel Margaret Chief Medical Office.. Chief Medical Officer Sep 06 Sell 2.5195 547 1,378 25,562 09/08/22
Koziel Margaret Chief Medical Office.. Chief Medical Officer Jun 01 Sell 2.0107 590 1,186 26,109 06/02/22
Hinshaw William President & CEO President & CEO Mar 16 Buy 1.91 13,089 25,000 48,012 03/18/22
Fehlner Paul SVP & Chief Legal Of.. SVP & Chief Legal Officer Mar 16 Buy 1.91 10,471 20,000 20,802 03/18/22
Epstein David R Director Director Mar 16 Buy 1.91 26,178 50,000 161,162 03/18/22
Crane Robert Chief Financial Offi.. Chief Financial Officer Mar 16 Buy 1.91 39,267 75,000 39,267 03/18/22
Flagship Ventures Fund IV Gene... 10% Owner 10% Owner Mar 16 Buy 1.91 6,319,371 12,069,999 4,465,866 03/18/22
Societe des Produits Nestle S.... 10% Owner 10% Owner Mar 16 Buy 1.91 3,141,361 6,000,000 7,446,902 03/16/22